The endogenous incretin glucagon-like peptide-1 (GLP-1) plays a prominent role in maintaining glucose homeostasis
With advancements in precision medicine and biomarker research, targeted therapies are expected to play an even more critical role in AR management
Adjustments follow data such as dose changes, switching peptides, adding supportive therapies like anti-inflammatories, or pausing treatment if adverse events occur
Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, et al
The key ingredients are Hydrolyzed Collagen, L-Cysteine, L-Glutathione, Vitamin C and E, and grape seed extract